A detailed history of Silverlake Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Silverlake Wealth Management LLC holds 4,414 shares of AMGN stock, worth $1.28 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
4,414
Previous 4,909 10.08%
Holding current value
$1.28 Million
Previous $1.58 Billion 27.26%
% of portfolio
0.44%
Previous 0.6%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$258.78 - $328.31 $128,096 - $162,513
-495 Reduced 10.08%
4,414 $1.15 Billion
Q3 2024

Oct 10, 2024

BUY
$309.38 - $337.38 $30,628 - $33,400
99 Added 2.06%
4,909 $1.58 Billion
Q2 2024

Aug 02, 2024

SELL
$262.75 - $319.31 $49,659 - $60,349
-189 Reduced 3.78%
4,810 $1.5 Billion
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $10,485 - $12,657
39 Added 0.79%
4,999 $1.42 Billion
Q4 2023

Jan 22, 2024

SELL
$255.7 - $288.46 $301,981 - $340,671
-1,181 Reduced 19.23%
4,960 $1.43 Billion
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $14,868 - $18,459
68 Added 1.12%
6,141 $1.65 Billion
Q2 2023

Jul 25, 2023

BUY
$214.27 - $253.37 $16,070 - $19,002
75 Added 1.25%
6,073 $1.35 Billion
Q1 2023

Apr 12, 2023

BUY
$225.79 - $275.2 $140,441 - $171,174
622 Added 11.57%
5,998 $1.45 Billion
Q4 2022

Feb 15, 2023

BUY
$229.03 - $291.01 $1.23 Million - $1.56 Million
5,376 New
5,376 $1.41 Billion
Q3 2022

Apr 06, 2023

SELL
$224.46 - $253.15 $3,591 - $4,050
-16 Reduced 0.3%
5,366 $1.21 Billion
Q2 2022

Apr 06, 2023

BUY
$230.71 - $256.74 $1,384 - $1,540
6 Added 0.11%
5,382 $1.31 Billion
Q1 2022

Apr 06, 2023

BUY
$219.27 - $242.57 $438 - $485
2 Added 0.04%
5,345 $1.29 Billion
Q4 2021

Apr 06, 2023

SELL
$198.88 - $227.6 $6,563 - $7,510
-33 Reduced 0.61%
5,343 $1.2 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Silverlake Wealth Management LLC Portfolio

Follow Silverlake Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverlake Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverlake Wealth Management LLC with notifications on news.